Science Market Update

UCLA: Meet Nearly 500 Top Researchers this Fall

Posted by BCI Staff on Wed, Aug 28, 2019

With 290 medical research centers and distinctive institutes, the University of California, Los Angeles is a powerhouse research university employing some of the leading life science researchers in the world. With a powerful global reputation, the University of California, Los Angeles offers a promising marketplace for lab suppliers working to market their biotech solutions and increase lab sales.

UCLA: Meet Nearly 500 Top Researchers this Fall

 

Perhaps you are a lab supplier with a long history of doing business with UCLA life science researchers, or maybe you are brand new to the market. Regardless of your time investment, increasing lab sales at the University of California, Los Angeles is as easy as taking advantage of Biotechnology Calendar, Inc.’s well-established connections at the university and exhibiting at the upcoming UCLA event. Why should you focus on this marketplace? Consider these most recent funding statistics for the University of California, Los Angeles:

  • 2017 Total R&D Expenditures: $1,076,917,000
  • 2017 Life Science R&D Expenditures: $761,824,000

  • 2017 Total R&D ranking: 12th
  • 2018 NIH Funding: $408,733,609
  • A $50 million philanthropic gift was awarded to the University of California, Los Angeles to support the five-year, $4.2 billion, fund raising Centennial Campaign.
  • UCLA's AIDS Malignancy Consortium, led by professor of medicine Ronald Mitsuyasu, received nearly $24 million in NIH funding in 2018 and over $136 million since 2006.

  • UCLA's AIDS Clinical Trials Group, led by professor of medicine Judith Currier, received $24.5 million in NIH funding in 2018 and over $483 million since 2006.

Read More

Tags: CA, University of California Los Angeles, California, funding resource, Los Angeles, LAVS

UCLA: $3.7M NIH Grant for Brain Imaging Technology Research

Posted by Gloria Beverage on Tue, Nov 27, 2018

A unique opportunity to advance research into the function of the human brain has been presented to three UCLA neuroscientists. Michele Basso, Dr. Peyman Golshani and Daniel Aharoni have received a $3.7 million, three-year grant from the National Institutes of Health (NIH) to develop imaging technology to record tens of thousands of neurons with the intent of learning how disease impacts the brain’s function.

Read More

Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, UCLA research funding, nih research funding, university research funding, Neurological Research, Brain Disease, Healthcare Research, Mental Disorders, lab equipment suppliers, brain cancer treatment

UCLA Receives Multi-million Grants and Gifts from Donors

Posted by Gloria Beverage on Fri, Aug 24, 2018

Two UCLA research programs have earned state and federal grants totaling $18.8 million, while two departments have been given $3.35 million in private endowments, according to university news reports. The Urology Department received $9.3 million from the state of California while the Fielding School of Public Health earned a $9.5 million grant from the National Institute of Drug Abuse (NIDA).

Read More

Tags: CA, UCLA School of Public Health, UCLA Funding statistics, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, cancer reserach, UCLA research funding, HIV research, Prostate cancer research, nih research funding

Grants Fund Multiple Alzheimer's Research Programs at UCLA

Posted by Gloria Beverage on Thu, Aug 09, 2018

 

An estimated 15 million Americans will develop Alzheimer’s disease by 2060, according to researchers at the UCLA Fielding School of Public Health. The December 2017 study is the first of its kind to estimate the numbers of Americans with preclinical Alzheimer’s disease.

 

Read More

Tags: CA, UCLA School of Public Health, new research funding, Alzheimer's Research, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, Alzheimer's research market, UCLA research funding, cytomegalovirus, Geriatrics

Research News: UCLA Stem Cell Study Making a Sensation

Posted by Rebecca Inch-Partridge on Thu, Jan 18, 2018

Most people think of paralysis in terms of not being able to move or walk. But there is another side to being paralyzed , the lack of sensation. The inability to feel pain leaves the person susceptible to burns from inadvertent contact with hot surfaces. Researchers at the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have developed a new protocol which could serve as the first step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.

Read More

Tags: Stem cell research, LAVS, UCLA, laboratory equipment suppliers, Lab Product Sales, research news, UC Los Angeles, BioResearch Product Faire, UCLA research funding, general lab supply, 2017 research funding, nih research funding

University of California Strengthens Cancer Research with Creation of New 5-School Consortium

Posted by Laura Braden on Mon, Oct 23, 2017

In the state of California, more than 176,000 residents arediagnosed with cancer each year and more than $14 billion is spent to fight this disease in California alone. The University of California system has five of the top cancer centers in the country within theseacademic institutions. In September these five UC cancer centers announced that they were teaming up to form a cancer consortium to provide researchers and physicians in California more opportunities to further their work on cancer-related topics. (Image courtesy of Wikimedia Commons)

Read More

Tags: cancer research, University of California, LAVS, SDVS, UCDMC, SFVS, BioResearch Product Faire Event, UCI, Biotechnology Vendor Showcase Event, 2018

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus

UCLA Leading $20M Project to Decrease Growing HIV Infection Rate Among Youths

Posted by Rebecca Partridge on Thu, Aug 10, 2017

“Despite dramatic improvements in the ability to treat and prevent HIV, the HIV rate among youth in America has doubled in the last 10 years,” Mary Jane Rotheram-Borus, director of the Global Center for Children and Families at UCLA stated in a recent article for the UCLA Newsroom. By 2020 the incidence of the disease among youths is expected to increase by 39%. Dr. Rotheram-Boras believes that if acutely infected youths were identified and treated during the period when their infectivity to others is 5-10 fold, then the medical community could reverse this trend and improve the long-term health of youths.  

(Image of UCLA courtesy of Wikimedia

Read More

Tags: LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, NIH grants, UC Los Angeles, BioResearch Product Faire, UCLA research funding, Laboratory product sales, general lab supply, 2017 research funding

UCLA Increasing Cannabis Research With Newly Established Research Group

Posted by Laura Braden on Tue, Aug 08, 2017

As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with such widespread access to cannabis, research if the drug has been limited due to the DEA classifying it as a Schedule I drug in the 1970s. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)

Read More

Tags: University of California Los Angeles, Cannabinoids, LAVS, UCLA, Biotechnology Vendor Showcase Event, 2017, cannabis research

UCLA: Medical Building Reopens After $65M Renovation

Posted by Rebecca Partridge on Thu, Jun 01, 2017

On April 20th UCLA celebrated the grand reopening of the Jules Stein Building after a $65M renovation. This building connects to the Doris Stein Building and the Edie & Lew Wasserman Building to make up the UCLA Stein Eye Institute. Combined, the three buildings provide nearly 300,000 square feet of functional space with over 20 specially equipped laboratories to support vision science investigations.

Read More

Tags: University of California Los Angeles, LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, new medical buildings, BioResearch Product Faire, David Geffen School of Medicine

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News